Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

For Kevetrin, after April. But, for best value and a deal from strength, Kevetrin needs that Phase 2/3a either underway or completed. That's when the billion dollar license happens, which would be no sooner than late 2014. In cancer trials and license negotiations, that's lightening fast.

But before that will come both Brilacidin and Prurisol. Since B already finished 2a and will likely begin a short duration 2b long before April, there is a good chance for a favorable license agreement anytime between now and mid-2014.

Prurisol 2/3a will likely start within a similar time frame as B. B is the most likely to have a license in place within the next 6 months. IMO, all depends on the terms offered by a big pharma for an earlier agreement as opposed to a later one.

When would Big Pharma start to take notice?